Multiple myeloma with acute light chain cast nephropathy.
Leung N, Rajkumar SV.
Blood Cancer J. 2023 Mar 29;13(1):46. doi: 10.1038/s41408-023-00806-w.
PMID:36990996
Myeloma light chain cast nephropathy, a review.
Sathick IJ, Drosou ME, Leung N.
J Nephrol. 2019 Apr;32(2):189-198. doi: 10.1007/s40620-018-0492-4. Epub 2018 May 5.
PMID:29730782
Light Chain Cast Nephropathy in Multiple Myeloma: Prevalence, Impact and Management Challenges.
Menè P, Stoppacciaro A, Lai S, Festuccia F.
Int J Nephrol Renovasc Dis. 2022 May 13;15:173-183. doi: 10.2147/IJNRD.S280179. eCollection 2022.
PMID:35592304
Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial.
Bridoux F, Carron PL, Pegourie B, Alamartine E, Augeul-Meunier K, Karras A, Joly B, Peraldi MN, Arnulf B, Vigneau C, Lamy T, Wynckel A, Kolb B, Royer B, Rabot N, Benboubker L, Combe C, Jaccard A, Moulin B, Knebelmann B, Chevret S, Fermand JP; MYRE Study Group.
JAMA. 2017 Dec 5;318(21):2099-2110. doi: 10.1001/jama.2017.17924.
PMID:29209721
Crystals in myeloma cast nephropathy.
Lin ZS, Zhou FD.
QJM. 2021 Dec 20;114(10):753-754. doi: 10.1093/qjmed/hcab197.
PMID:34264348
Light Chain Cast Nephropathy: Practical Considerations in the Management of Myeloma Kidney-What We Know and What the Future May Hold.